Revised Government Standards Now Allow Public Advertising of OTC Products

The Korea Food and Drug Administration (KFDA) recently announced an official enforcement of its revised regulatory provision governing the public advertising standards for pharmaceutical products, which was proposed last year under the purpose of preventing drug abuse and misuse by the public.

Under the revised provision, the scope of drug public advertising ban has been redefined with the ...